M K Danks - JoVE Visualize

Showing results (21-30 of 56) with videos related to

Pageof 6

Sort By:

Cancer Research|April 10, 1999

The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesteraseC L Morton, R M Wadkins, M K Danks, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1994

Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell lineC D Evans, S E Mirski, M K Danks, et al.

Oncology Research|January 1, 1995

A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agentsS Hashimoto, M K Danks, S Chatterjee, et al.

Progress in Clinical and Biological Research|January 1, 1986

Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell linesW T Beck, M K Danks, M C Cirtain, et al.

Oncology Research|January 1, 1992

Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoproteinB Granzen, D E Graves, B C Baguley, et al.

Cell Death and Differentiation|April 14, 1999

Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell linesM K Danks, D O Whipple, C R McPake, et al.

Cancer Research|August 29, 1998

Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzymeP M Potter, J S Wolverton, C L Morton, et al.

Biochemistry|November 29, 1988

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26M K Danks, C A Schmidt, M C Cirtain, et al.

Cytometry|July 17, 1998

In situ subcellular localization of epitope-tagged human and rabbit carboxylesterasesP M Potter, J S Wolverton, C L Morton, et al.

Cancer Genetics and Cytogenetics|October 1, 1993

Loss of tumorigenicity in a methotrexate-resistant human leukemia cell lineA B Hill, J M Trent, F H Thompson, et al.

Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:

Pageof 6

Cancer Research|April 10, 1999

The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesteraseC L Morton, R M Wadkins, M K Danks, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1994

Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell lineC D Evans, S E Mirski, M K Danks, et al.

Oncology Research|January 1, 1995

A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agentsS Hashimoto, M K Danks, S Chatterjee, et al.

Progress in Clinical and Biological Research|January 1, 1986

Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell linesW T Beck, M K Danks, M C Cirtain, et al.

Oncology Research|January 1, 1992

Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoproteinB Granzen, D E Graves, B C Baguley, et al.

Cell Death and Differentiation|April 14, 1999

Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell linesM K Danks, D O Whipple, C R McPake, et al.

Cancer Research|August 29, 1998

Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzymeP M Potter, J S Wolverton, C L Morton, et al.

Biochemistry|November 29, 1988

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26M K Danks, C A Schmidt, M C Cirtain, et al.

Cytometry|July 17, 1998

In situ subcellular localization of epitope-tagged human and rabbit carboxylesterasesP M Potter, J S Wolverton, C L Morton, et al.

Cancer Genetics and Cytogenetics|October 1, 1993

Loss of tumorigenicity in a methotrexate-resistant human leukemia cell lineA B Hill, J M Trent, F H Thompson, et al.

Pageof 6